Corcept Therapeutics Incorporated (CORT) — Quality & forensics
As of 2026-10-28 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 27
- Quality 49
- Growth 59
- Balance sheet 89
- Cash quality 55
- Capital allocation 40
- Momentum 58
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the CORT chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-28
Quick answers
What is Corcept Therapeutics Incorporated's Closelooknet quality reading?
The composite reads 54/100 across 7 modules, as of 2026-10-28: valuation 27, quality 49, growth 59, balance sheet 89, cash quality 55, capital allocation 40, momentum 58. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Corcept Therapeutics Incorporated's Altman Z-Score?
32.54, which sits in the safe zone (above 2.99) as of 2026-10-28. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Corcept Therapeutics Incorporated's Piotroski F-Score?
4 of 8, as of 2026-10-28. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Corcept Therapeutics Incorporated's Beneish M-Score indicate?
-2.75 — below the −1.78 manipulation-risk threshold, as of 2026-10-28. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Mentioned on Closelooknet
Where CORT appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- IOVA Iovance Biotherapeutics Incindustry
- FTRE Fortrea Holdings Inc.industry
- ABSI Absci Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- REPL Replimune Group Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- MRNA Moderna Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- XNCR Xencor Incindustry
- IRON Disc Medicine Inc.industry
- LEGN Legend Biotech Corpindustry
- BHVN Biohaven Ltd.industry